Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2012, Article ID 302093, 8 pages
Clinical Study

Efficacy and Safety of Low-Dose Peginterferon Alpha-2a Plus Ribavirin on Chronic Hepatitis C

Institute of Infectious Diseases, Southwest Hospital, The Third Military Medical University, Chongqing 400038, China

Received 8 October 2012; Accepted 15 November 2012

Academic Editor: Edoardo Giovanni Giannini

Copyright © 2012 Zehui Yan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [2 citations]

The following is the list of published articles that have cited the current article.

  • YuanYuan Ding, Mei Zhang, JingFeng Xu, JiaMing Bian, and Fan Yang, “Gene-directed personalized medication and clinical practice in the General Hospital of Beijing Military Command of PLA,” Pharmaceutical Care and Research, vol. 14, no. 3, pp. 161–165, 2014. View at Publisher · View at Google Scholar
  • Yoshiaki Iwasaki, Ryo-ichi Okamoto, Yasushi Ishii, Yasuyuki Araki, Noriaki Hashimoto, and Kazuhide Yamamoto, “Randomized trial of low-dose peginterferon α-2b plus low and escalating doses of ribavirin in older patients with chronic hepatitis C with high viral load genotype 1,” Journal of Medical Virology, 2015. View at Publisher · View at Google Scholar